16-2324484-C-T
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 2P and 3B. PM2BP4_ModerateBP6
The NM_001089.3(ABCA3):c.367G>A(p.Asp123Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000601 in 1,610,922 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001089.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ABCA3 | NM_001089.3 | c.367G>A | p.Asp123Asn | missense_variant | 6/33 | ENST00000301732.10 | NP_001080.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ABCA3 | ENST00000301732.10 | c.367G>A | p.Asp123Asn | missense_variant | 6/33 | 1 | NM_001089.3 | ENSP00000301732.5 | ||
ABCA3 | ENST00000382381.7 | c.367G>A | p.Asp123Asn | missense_variant | 6/32 | 1 | ENSP00000371818.3 | |||
ABCA3 | ENST00000567910.1 | c.367G>A | p.Asp123Asn | missense_variant | 5/6 | 1 | ENSP00000454397.1 | |||
ABCA3 | ENST00000563623.5 | n.930G>A | non_coding_transcript_exon_variant | 6/20 | 1 |
Frequencies
GnomAD3 genomes AF: 0.000296 AC: 45AN: 152012Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000298 AC: 74AN: 248330Hom.: 0 AF XY: 0.000297 AC XY: 40AN XY: 134636
GnomAD4 exome AF: 0.000633 AC: 923AN: 1458792Hom.: 0 Cov.: 31 AF XY: 0.000604 AC XY: 438AN XY: 725732
GnomAD4 genome AF: 0.000296 AC: 45AN: 152130Hom.: 0 Cov.: 31 AF XY: 0.000296 AC XY: 22AN XY: 74354
ClinVar
Submissions by phenotype
Interstitial lung disease due to ABCA3 deficiency Uncertain:2Benign:1
Benign, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Aug 29, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | May 04, 2022 | - - |
Hereditary pulmonary alveolar proteinosis Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 06, 2014 | The p.D123N variant (also known as c.367G>A), located in coding exon 3 of the ABCA3 gene, results from a G to A substitution at nucleotide position 367. The aspartic acid at codon 123 is replaced by asparagine, an amino acid with highly similar properties. This variant was observed with a pathogenic alteration in the SFTPC gene in a patient affected with interstitial lung disease (ILD) and his daughter with pathology findings of ILD. A second daughter with the SFTPC mutation only was not found to have any indication of ILD (Crossno PF et al. Chest. 2010;137(4):969-73). This variant was previously reported in the SNPDatabase as rs145087575. Based on data from the NHLBI Exome Sequencing Project (ESP), the A allele has an overall frequency of approximately 0.05% (6/12996) total alleles studied and 0.07% (6/8600) European American alleles. This amino acid position is not well conserved on sequence alignment. In addition, this alteration is predicted to be tolerated by in silico analysis. Since clinical data on this variant is limited at this time, its clinical significance is unclear. - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Aug 14, 2014 | Asp123Asn in exon 6 of ABCA3: This variant is not expected to have clinical sign ificance due to a lack of conservation across species, including mammals. Of not e, 5 mammals (naked mole rat, weddell seal, elephant, opossum, and Tasmanian dev il) have an asparagine (Asn) at this position despite high nearby amino acid con servation. In addition, computational prediction tools do not suggest a high lik elihood of impact to the protein. This variant has also been identified in 6/860 0 of European American chromosomes by the NHLBI Exome Sequencing Project (http:/ /evs.gs.washington.edu/EVS/; dbSNP rs145087575). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at